Q. He

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Qing He, Mithat Gonen, Michel Sadelain, 2014, Science Translational Medicine.

CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia

Qing He, Lindsay G. Cowell, Michel Sadelain, 2013, Science Translational Medicine.

459. Evaluation of Miltenyi ExpAct and TransAct CD3/28 Beads for CAR-T Cell Manufacturing

M. Sadelain, Teresa Wasielewska, Jinrong Qu, 2016 .

Impact of the Conditioning Chemotherapy On Outcomes in Adoptive T Cell Therapy: Results From a Phase I Clinical Trial of Autologous CD19-Targeted T Cells for Patients with Relapsed CLL

M. Sadelain, Teresa Wasielewska, M. Olszewska, 2012 .

Improved Clinical Outcomes in Chinese Renal Allograft Recipients Receiving Lower Dose Immunosuppressants

Jianyong Wu, Jiang‐hua Chen, Yi-ming Wang, 2004, Transplantation.